PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
22.98%
Net income growth at 50-75% of ZETA's 40.68%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-4.60%
Both reduce yoy D&A, with ZETA at -1.61%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-62.95%
Negative yoy deferred tax while ZETA stands at 53.19%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
133.73%
SBC growth well above ZETA's 10.68%. Michael Burry would flag major dilution risk vs. competitor’s approach.
98.38%
Working capital change of 98.38% while ZETA is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
779.62%
AR growth while ZETA is negative at -367.30%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.15%
Lower 'other working capital' growth vs. ZETA's 100.00%. David Dodd would see fewer unexpected short-term demands on cash.
-110.50%
Both negative yoy, with ZETA at -192.80%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
23.77%
Operating cash flow growth 1.25-1.5x ZETA's 20.83%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
44.83%
CapEx growth well above ZETA's 14.14%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-6.33%
Both yoy lines negative, with ZETA at -26.79%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-134.84%
Negative yoy purchasing while ZETA stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
129.99%
Liquidation growth of 129.99% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-70.34%
Both yoy lines negative, with ZETA at -39.54%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
72.80%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
120.17%
Issuance growth of 120.17% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-92.99%
Both yoy lines negative, with ZETA at -23.83%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.